Oct. 23, 2025 — Working together, Grundium, a specialist in digital imaging for pathology, and Washington University, St. Louis (WashU), have shown that Grundium’s technology matches the diagnostic accuracy of traditional methods while decreasing turnaround times and improving patient care. Using Grundium's compact scanners, the university’s pathology team transformed how rapid on-site evaluations (ROSE) and frozen sections are performed across six different locations.

Oct. 22, 2025 —  Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 Endoscopic Imaging System — a smartly designed single-unit processor and light source (EP-8000) featuring several features that enhance endoscopic image quality, therapeutic capabilities, and workflow efficiencies. The next-generation platform will be demonstrated at the American College of Gastroenterology (ACG) 2025 Oct.r 26 -28, in Phoenix, Arizona.

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the University of Exeter.

Oct. 22, 2025 — Vistim Labs has announced that its flagship product, Ceregram, is officially ready for launch in neurology offices in the United States, marking a major milestone in the company’s mission to transform how clinicians monitor the effectiveness of treatment for dementia, Alzheimer’s, Parkinson's and other neurological conditions. 

New Report: Radiotherapy Contributes to 40% of All Cancer Cures

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and attention, according to a new impact report released at the American Society for Radiation Oncology’s (ASTRO) 67thAnnual Meeting.

Oct. 9, 2025 — Harrison.ai has received three FDA Breakthrough Device Designations for CT imaging solutions, further solidifying its position at the forefront of next-generation AI for driving efficient, quality patient care.

Oct. 21, 2025 — GT Medical Technologies has announced the interim results from its ROADS clinical trial (Randomized Controlled Trial of Resection [Surgery] and GammaTile versus Standard of Care) in patients with operable, newly diagnosed brain metastases.1

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive findings from a proof-of-concept (POC) study with Bayer evaluating Subtle Medical's investigational SubtleGAD technology.

Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced digital innovation and medical technologies to the health system to deliver high-quality, timely and consistent care that meets the individual patient’s health care needs.

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care teams identify, prioritize, and act on critical patient data.1 Viz Assist marks a major step forward in Viz.ai’s mission to use technology to reduce time to treatment and improve patient outcomes.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now